🚀 VC round data is live in beta, check it out!
Cogstate Valuation Multiples
Discover revenue and EBITDA valuation multiples for Cogstate and similar public comparables like Echo IQ, SOPHiA Genetics, National Research, CareNet and more.
Cogstate Overview
About Cogstate
Cogstate Ltd is a cognitive science company. The principal activity of the group is the Creation, validation, and commercialisation of digital brain health assessments; and the Design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments and reporting. Its operating segment includes Clinical Trials, Healthcare, and Administration. The company generates maximum revenue from the Clinical Trials segment. In the clinical trials segment, technology and services are sold to pharmaceutical and biotechnology companies. The company derives revenue from the sale of licensed software and cognitive testing services.
Founded
1999
HQ
Employees
352
Website
Financials (LTM)
EV
$238M
Cogstate Financials
Cogstate reported last 12-month revenue of $58M and EBITDA of $17M.
In the same LTM period, Cogstate generated $34M in gross profit, $17M in EBITDA, and $11M in net income.
Revenue (LTM)
Cogstate P&L
In the most recent fiscal year, Cogstate reported revenue of $53M and EBITDA of $17M.
Cogstate expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $58M | XXX | $53M | XXX | XXX | XXX |
| Gross Profit | $34M | XXX | $31M | XXX | XXX | XXX |
| Gross Margin | 58% | XXX | 58% | XXX | XXX | XXX |
| EBITDA | $17M | XXX | $17M | XXX | XXX | XXX |
| EBITDA Margin | 30% | XXX | 32% | XXX | XXX | XXX |
| EBIT Margin | 24% | XXX | 24% | XXX | XXX | XXX |
| Net Profit | $11M | XXX | $10M | XXX | XXX | XXX |
| Net Margin | 19% | XXX | 19% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Cogstate Stock Performance
Cogstate has current market cap of $271M, and enterprise value of $238M.
Market Cap Evolution
Cogstate's stock price is $1.58.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $238M | $271M | -0.4% | XXX | XXX | XXX | $0.06 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCogstate Valuation Multiples
Cogstate trades at 4.1x EV/Revenue multiple, and 13.8x EV/EBITDA.
EV / Revenue (LTM)
Cogstate Financial Valuation Multiples
As of April 5, 2026, Cogstate has market cap of $271M and EV of $238M.
Equity research analysts estimate Cogstate's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Cogstate has a P/E ratio of 24.0x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $271M | XXX | $271M | XXX | XXX | XXX |
| EV (current) | $238M | XXX | $238M | XXX | XXX | XXX |
| EV/Revenue | 4.1x | XXX | 4.5x | XXX | XXX | XXX |
| EV/EBITDA | 13.8x | XXX | 14.1x | XXX | XXX | XXX |
| EV/EBIT | 17.0x | XXX | 18.3x | XXX | XXX | XXX |
| EV/Gross Profit | 7.1x | XXX | 7.8x | XXX | XXX | XXX |
| P/E | 24.0x | XXX | 26.7x | XXX | XXX | XXX |
| EV/FCF | 23.5x | XXX | 28.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Cogstate Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Cogstate Margins & Growth Rates
Cogstate's revenue in the last 12 month grew by 12%.
Cogstate's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Cogstate's rule of 40 is 45% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Cogstate's rule of X is 67% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Cogstate Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 12% | XXX | 13% | XXX | XXX | XXX |
| EBITDA Margin | 30% | XXX | 32% | XXX | XXX | XXX |
| EBITDA Growth | 19% | XXX | 4% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 45% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 67% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 24% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 37% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Cogstate Public Comps
See public comps and valuation multiples for other Health Data & Analytics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
| SOPHiA Genetics | XXX | XXX | XXX | XXX | XXX | XXX |
| National Research | XXX | XXX | XXX | XXX | XXX | XXX |
| CareNet | XXX | XXX | XXX | XXX | XXX | XXX |
| Owlet | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cogstate M&A Activity
Cogstate acquired XXX companies to date.
Last acquisition by Cogstate was on XXXXXXXX, XXXXX. Cogstate acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Cogstate
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCogstate Investment Activity
Cogstate invested in XXX companies to date.
Cogstate made its latest investment on XXXXXXXX, XXXXX. Cogstate invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Cogstate
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Cogstate
| When was Cogstate founded? | Cogstate was founded in 1999. |
| Where is Cogstate headquartered? | Cogstate is headquartered in Australia. |
| How many employees does Cogstate have? | As of today, Cogstate has over 352 employees. |
| Is Cogstate publicly listed? | Yes, Cogstate is a public company listed on Australian Securities Exchange. |
| What is the stock symbol of Cogstate? | Cogstate trades under CGS ticker. |
| When did Cogstate go public? | Cogstate went public in 2004. |
| Who are competitors of Cogstate? | Cogstate main competitors are Echo IQ, SOPHiA Genetics, National Research, CareNet. |
| What is the current market cap of Cogstate? | Cogstate's current market cap is $271M. |
| What is the current revenue of Cogstate? | Cogstate's last 12 months revenue is $58M. |
| What is the current revenue growth of Cogstate? | Cogstate revenue growth (NTM/LTM) is 12%. |
| What is the current EV/Revenue multiple of Cogstate? | Current revenue multiple of Cogstate is 4.1x. |
| Is Cogstate profitable? | Yes, Cogstate is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Cogstate? | Cogstate's last 12 months EBITDA is $17M. |
| What is Cogstate's EBITDA margin? | Cogstate's last 12 months EBITDA margin is 30%. |
| What is the current EV/EBITDA multiple of Cogstate? | Current EBITDA multiple of Cogstate is 13.8x. |
| What is the current FCF of Cogstate? | Cogstate's last 12 months FCF is $10M. |
| What is Cogstate's FCF margin? | Cogstate's last 12 months FCF margin is 17%. |
| What is the current EV/FCF multiple of Cogstate? | Current FCF multiple of Cogstate is 23.5x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.